This website is intended for healthcare professionals only who are working in Gulf Countries: United Arab of Emirates, Kuwait, Qatar, Bahrain and Oman
calandercalander

LDL-C Predictability Calculator

For Re-assessing The Dyslipidemia Management Path of "Very High Risk" Patients (This LDL-C predictability calculator is based on 2019 ESC/EAS Guidelines for the management of dyslipidemia: lipid modification to reduce cardiovascular risk)*

*Reference: European Heart Journal, Volume 41, Issue 1 ,1 January 2020, Pages 188–111, https://doi.org/10.1093/eurheartj/ehz455

Amgen Logo

Back to Top

Do you want to link to this Amgen Site outside the UK and leave re-path.com?

YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Do you want to link to this Amgen Site outside the UK and leave re-path.com?

YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Back to Top

Do you want to link to this Amgen Site outside the UK and leave re-path.com?

YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Do you want to link to this Amgen Site outside the UK and leave re-path.com?

YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.